137P First-in-human results from a phase I dose-escalation study of VSV-GP (BI 1831169) in patients with advanced solid tumors
De-escalation
DOI:
10.1016/j.iotech.2023.100609
Publication Date:
2023-12-08T11:09:26Z
AUTHORS (8)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....